Fate therapeutics to webcast conference call reporting second quarter 2022 financial results

San diego, july 25, 2022 (globe newswire) -- fate therapeutics, inc. (the “company” or “fate therapeutics”) (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that the company will host a conference call and live audio webcast on wednesday, august 3, 2022 at 5:00 pm et to report its second quarter 2022 financial results and provide a corporate update.
FATE Ratings Summary
FATE Quant Ranking